Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitric oxide synthases (NOS) are a family of enzymes that catalyze the production of nitric oxide (NO) from L-arginine. NO is a critical signaling molecule involved in numerous physiological processes, including neurotransmission, vascular regulation, and immune response. There are three main isoforms: NOS1 (neuronal), NOS2 (inducible), and NOS3 (endothelial). Dysregulation of NOS activity is implicated in various diseases.
NOS inhibitors block the production of nitric oxide by inhibiting the enzymatic activity of NOS isoforms. This can involve competitive binding to the active site, disruption of cofactor binding, or interference with the enzyme's dimerization or conformational changes.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric Oxide Synthase (NOS).